NCT04596332

Central Venous Pressure Monitoring and Prognosis of High-risk Operating Patients

Completed Last updated 22 October 2020

What this trial tests

trial testing no intervention measures in Central Venous Pressure in 196 participants. Completed in 30 March 2020.

Timeline

1 February 2014

Primary endpoint
31 March 2018

30 March 2020

Quick facts

Lead sponsor	Fujian Provincial Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	196
Start date	1 February 2014
Primary completion	31 March 2018
Estimated completion	30 March 2020

Drugs / interventions tested

• no intervention measures

Conditions studied

• Central Venous Pressure — all drugs for Central Venous Pressure →

Sponsor

Fujian Provincial Hospital

Who can join

Adults 18 to 80, any sex, with Central Venous Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

While central venous pressure measurement is used to guide fluid management in high risk surgical patients during perioperative period, the relationship between the value of central venous pressure and organ dysfunction and prognosis of high-risk operating patients is unknow. In this study, we conducted a retrospective study of the relationship between the initial levels of CVP with organ dysfunction, the severity of illness, the length of ICU stay, and prognosis of critically ill patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Optimization of central venous pressure during the perioperative period is associated with improved prognosis of high-risk operation patients.
   Wu J, Li J, Chen H, Shang X, et al · · 2023 · cited 3× · PMID 37188112 · DOI 10.1016/j.jointm.2022.06.003